Oestrogen-induced renal carcinoma.
Oestrogen may be implicated as an aetiological factor in the development of some renal carcinomas in man. The development of a renal carcinoma in 2 patients who had been treated with low-dose oestrogen for periods of 3 and 3 1/2 years because of prostatic carcinoma is described. It is suggested that patients receiving prolonged oestrogen therapy should be evaluated for the presence of a renal carcinoma at regular intervals.
D000368:Aged; D000792:Angiography; D001859:Bone Neoplasms / Q000473:pathology; D004054:Diethylstilbestrol / Q000009:adverse effects*; D006801:Humans; D007680:Kidney Neoplasms / Q000139:chemically induced* / Q000000981:diagnostic imaging / Q000473:pathology; D008297:Male; D009362:Neoplasm Metastasis; D011471:Prostatic Neoplasms / Q000188:drug therapy / Q000473:pathology; D013997:Time Factors; D014567:Urography
D004054:Diethylstilbestrol